Abstract
We report a new fluorescent detection method for propofol based on graphene quantum dots (GQDs). Citric acid (CA) was selected as the carbon precursor, and fluorescent GQDs were prepared by carbonizing CA. The product, which efficiently quenched the fluorescence of GQDs, could be obtained through the oxidation of propofol in the presence of horseradish peroxidase and hydrogen peroxide. The fluorescence intensity ratio of GQDs (F/F0) was positively correlated with the concentration of propofol, which ranged within 5.34–89.07 mg l−1, the limit of detection was 0.5 mg l−1 and the limit of quantity was 5.34 mg l−1. The developed fluorescence method reported in the present study is simple, sensitive, reproducible, and can serve in determining propofol contents in emulsions.
Keywords: graphene quantum dots, propofol, fluorescence, emulsions
1. Introduction
Graphene quantum dots (GQDs), emerged as novel materials in the recent decade, and have demonstrated superiority in numerous privileged properties [1]. GQDs are considered superior due to facile preparation methodologies, low toxicity, high luminescent properties and high photostability against photobleaching and blinking, which have attracted substantial attention [2–7]. GQDs have been widely employed in many applications such as the detection of proteins [8], nucleic acids [9,10], inorganic ions [11,12], small organic molecules [13,14] and biological imaging [15,16].
As a new potential tool in analytical chemistry, most of the sensors and biosensors were developed by conventional, doped or functionalized GQDs, in order to improve the sensitivity, selectivity and specificity of fluorescent detection [17]. Based on such attractive features, GQD nanoprobes have been employed in the detection of Fe3+ [12], Hg2+ [18], Cl− [11], trinitrotoluene, hydroquinone [13] and glucose [19]. GQDs have also been used in the fluorescence detection of phenols, which exhibited an enhanced detection sensitivity level (10−8–10−10 mol l−1). A recent study demonstrated an effective GQD-based approach, and has been reported to be a sensitive method for the detection of dihydroxybenzene (DHB) [20]. Ruiling Sun et al. found GQDs had the potential to be applied for analysing the contents of phenol in industrial water using the resonance light scattering method [21]. In food packaging, a detection method based on GQDs has been reported as an efficient approach for the analysis of bisphenol A [22]. Furthermore, GQDs coated with molecularly imprinted polymer have also been reported for the determination of 4-nitrophenol in water samples [23]. The potential use of GQDs as optical nanoprobes for the determination of phenolic contents in olive oil and bifunctional nanoprobes has been applied in a sensing platform for the non-enzymatic photoluminescence detection of hydroquinone [13,24]. However, these methods are mainly used for the detection of water-soluble phenolic compounds, a GQDs-based detection method for fat-soluble phenolic compounds has not been reported to date. This experiment was to study the detection method for a fat-soluble phenolic anaesthetic propofol (2,6-diisopropylphenol) based on GQDs.
In this study, we aimed to investigate the application of GQDs for the determination of propofol in emulsions. Propofol is a short-acting intravenous anaesthetic agent frequently used for anaesthetic induction, maintenance and sedation [25]. Propofol metabolizes quickly in human beings and requires continuous infusion. Owing to individual differences, propofol metabolism is highly variable in nature, which motivated our laboratory to develop a simple detection method for monitoring propofol in clinical settings [26–28].
To date, propofol detection methods include, gas chromatography–mass spectrometry (GC–MS) [29], liquid chromatography–mass spectrometry (LC–MS) [30], high-performance liquid chromatography (HPLC) [31], capillary electrophoresis [32], fluorophotometry [33] and UV–Vis spectrophotometry [34–36]. Fluorophotometry is a simple, sensitive and easily detectable technique [37]. Thus, establishing a rapid method to detect propofol is important for the safety and effectiveness of clinical anaesthetics. In the present study, we report a method for determining propofol in emulsions based on GQDs and fluorescent spectrophotometry. GQDs have been employed as novel nanofluorescence probes designed to detect propofol in emulsion with sensitivity and selectivity. The proposed simple and environment-friendly approach provides a novel method to probe the practical application of GQDs in propofol emulsions. The presently developed method was based on the oxidative reaction of propofol in the presence of hydrogen peroxide (H2O2) and horseradish peroxidase (HRP) to obtain the corresponding benzoquinone, which could quench the fluorescence of GQDs efficiently, as depicted in scheme 1.
Scheme 1.

Schematic illustration of propofol detection.
2. Material and methods
2.1. Reagents and standards
Propofol standard (greater than 99.8%) was purchased from the National Institute for Food and Drugs Control in China. Propofol injection (1% w/v, 10 mg ml−1) was purchased from Guori Pharmaceutical Co., Ltd (Sichuan, China). Citric acid (CA, 99%) and NaOH were obtained from Shengao Chemical Reagent Co., Ltd. Absolute alcohol and glycerol were purchased from Tianjin Fuyu Chemical Co., Ltd (Tianjin, China). H2O2 (30%, v/v) was obtained from Tianjin Beilian Chemicals Co., Ltd (Tianjin, China). HRP (greater than 150 units mg−1) was purchased from Yuanye Biological Technology Co., Ltd (Shanghai, China). Egg yolk lecithin was purchased from Shanghai Lanji Science and Technology development Co., Ltd (Shanghai, China). Soya bean oil was purchased from Jiangxi Yipusheng Pharmaceuticals Co., Ltd (Nanchang, China). All reagents were of analytical grade and used without additional purification.
2.2. Instrumentation
UV–Vis absorption spectra were obtained using a Shimadzu UV–2550 spectrophotometer (Shimadzu, Japan). A Shimadzu RF-5301 fluorescence spectrometer (Shimadzu, Japan) was used to record the fluorescence emission spectra of GQDs using a quartz cuvette cell (path length: 1 cm). An IRPrestige-21 FT-IR spectrometer (Shimadzu, Japan) was used to obtain the Fourier transform infrared (FTIR) spectra. Transmission electron microscopy (TEM) was conducted through a JEM-1230 transmission electron microscope (JEOL, Japan) operating at 200 kV. HPLC was carried out using chromatography apparatus (Shimadzu, Japan) equipped with an LC-20AT pump, SPD-M20A diode array detector, CBM-20A controller and CTO-20A column oven. A Shim-pack VP-ODS C18 column (5 µm, 250 × 4.6 mm internal diameter; Shimadzu) was used for reserve phase HPLC. The pH was measured with a PHSJ-3F digital pH-meter (Leici, China).
2.3. Preparation of graphene quantum dots
GQDs were synthesized by incompletely carbonized CA, as previously described by Dong et al. [7]. Briefly, 2.0 g of CA was placed in a round bottom flask, which was subsequently heated to 210°C in a heating mantle. After 50 min, when the liquid CA turned to pale-yellow and then to orange, 65 ml of 10 mg ml−1 NaOH was quickly added with stirring to adjust the pH of the mixed solution to 7.0, and the solution was stored at 4°C until used.
2.4. Analysis of propofol in the presence of horseradish peroxidase/hydrogen peroxide
For the propofol assay, 1055 mg l−1 propofol solution was diluted with 96% ethanol to obtain different concentrations of propofol solutions. Then, 96% ethanol was used for dilution of the propofol emulsion injection, in order to obtain higher solubility of propofol in real sample emulsion.
A 0.2 mol l−1 phosphate buffer was prepared from potassium dihydrogen phosphate, and adjusted to pH 7.4 by adding 0.2 mol l−1 sodium hydroxide solution. Then, H2O2 and HRP were dissolved in and diluted with buffer solution, respectively [33]. Next, 0.5 ml of 20 mmol l−1 H2O2 was added, followed by 0.5 ml of propofol solution with different concentrations and 0.5 ml of 2.5 mg ml−1 HRP. The mixture was heated at 40°C for 5 min. Then, 1.5 ml of 0.5% GQDs were added to a final volume of 3 ml. The obtained solution was shaken gently and stored for half an hour at room temperature before performing the fluorescence spectrophotometry [20]. The fluorescence quenching spectra were recorded under the following conditions: an excitation wavelength of 365 nm, a maximum emission of 460 nm, and slit widths of 5.0 and 5.0 nm for excitation and emission, respectively.
3. Results and discussion
3.1. Spectral characterization of graphene quantum dots
The incompletely carbonized CA was used for surface-passivation of GQDs. After moderate pyrolysis, CA could be partially carbonized to form GQDs. As GQDs contained abundant small sp2 clusters which were non-uniform in size and poorly passivated [7], and thus were possibly isolated within the sp3 C–O matrix, the GQDs exhibited an excitation-dependent photoluminescent (PL) activity.
The PL emission and UV–Vis absorption spectra of the GQDs solution are depicted in figure 1a. The UV–Vis absorption spectrum of the prepared GQDs showed a shoulder peak at 340 nm (figure 1a). GQDs revealed fluorescence properties, as shown by the apparent absorption band at 365 nm, corresponding to the excitation spectra and displayed the fluorescence intensity (maximum emission) at 460 nm. Based on UV–Vis spectral results, it is possible to infer that CA polymerization changed the material structure to attain fluorescence characteristics.
Figure 1.
(a) UV–Vis absorption spectrum (black line) and fluorescence emission spectrum (coloured line) of GQDs. (b) Emission spectra of the GQDs with excitation of different wavelengths. Inset: photographs of the GQDs solution taken under visible light (left) and 360 nm of UV light (right).
In order to further characterize the optical characteristics of GQDs, a comprehensive photoluminescence study was conducted at different excitation wavelengths (figure 1b). The prepared GQDs solution also emitted blue light upon excitation at 320–400 nm. Maximum emission was achieved at 360 nm of excitation, as shown in figure 1b. GQDs exhibited an excitation-dependent PL behaviour.
3.2. Fourier transform infrared spectral characteristics and transmission electron microscopy image of graphene quantum dots
FTIR spectra were recorded to investigate and characterize the chemical bonding states of GQDs (figure 2a). The FTIR spectrum of the GQDs revealed intense absorption bands. The CA and GQDs revealed –OH stretching vibrations at 3394 cm−1 and –C = O stretching vibrations at 1751 cm−1, but the GQDs revealed –CH2 stretching vibrations at 2930 cm−1 and C = C stretching vibrations at 1527 cm−1. These results indicate the dehydration of CA during hydrothermal polymerization. The peak appeared at 1404 cm−1, due to the C–O bond stretching. CA was completely carbonized to form graphene oxide (GO). The C–H bond of GO was not observed in the FTIR spectra, but stretching vibration of the C–O–C group appeared at 1012 cm−1. Under FTIR characterization, GQDs revealed the absorption for the C–H bond, but without the absorption of the C–O–C functional group, which suggests that GQDs were the products of the incomplete carbonation of CA.
Figure 2.
(a) FTIR spectra of citric acid and GQDs. (b) TEM image of GQDs.
The particle size of GQDs was determined, and the sample was analysed by TEM. The TEM image of GQDs are shown in figure 2b. The diameter of GQDs ranged within 10–85 nm, and most of the fractions were large particles with inhomogeneous sizes, indicating that CA carbonation altered the particle size (figure 2b). Shujun Wang et al. suggested that the PL properties of GQDs are possibly due to the competition between large particles of broad size distribution and a narrow size range (0.7–1.0 nm) with the small particles. A fraction of small uniformly sized GQDs (0.7–1.0 nm) contributes to the excitation-independent fluorescence, whereas the fraction of large inhomogeneously sized GQD (ranging from 35 to 85 nm) structures dominated the excitation-dependent fluorescence [38]. It was inferred that in the present investigation, the large fraction of inhomogeneously sized GQDs was dominant in quantity. Hence, an excitation-dependent photoluminescence was observed.
3.3. Optimization of experimental parameters for propofol detection
The fluorescence quenching of GQDs occurred due to the oxidation of propofol by H2O2 and HRP to form benzoquinone. This has been reported to be an efficient electron acceptor that could mediate the electron transfer of the excited luminescence material, which finally leads to the effective fluorescence quenching of GQDs [20]. It is noteworthy that H2O2, HRP and the propofol solution did not induce the fluorescence quenching of GQDs. However, the product that reacted with H2O2, HRP and propofol was observed to induce GQDs fluorescence quenching.
In order to improve the analytical characteristics, the developed method was optimized against several parameters such as the concentration of H2O2 and HRP, and the relationship between incubation time and GQDs fluorescence intensity. In order to accomplish this, several concentrations of H2O2 were prepared. When the HRP concentration was 2.27 mg ml−1, the H2O2 concentration was studied within the range of 10–50 mmol l−1. The quenched fluorescence spectrum of each H2O2 solution was measured. Fluorescence quenching was highest during the reaction with 20 mmol l−1 of H2O2 (figure 3a), which was selected for the subsequent trials.
Figure 3.
Effect of concentrations of H2O2 and HRP, heating time and incubation time on F/F0. (a) Effect of H2O2 concentration on fluorescence. (b) Effect of HRP concentration on fluorescence. (c) Effect of heating time on fluorescence. (d) Effect of incubation time on fluorescence.
With HRP as the catalyst, enzyme concentrations ranging within 0.05–2.50 mg ml−1 were investigated when the H2O2 concentration was 20 mmol l−1. The high enzyme concentration resulted in high quenching (figure 3b). Further studies were conducted using the HRP concentration (2.50 mg ml−1) as optimal.
Heating duration affects both the reactant formation and enzyme activity. The influence of heating time was studied within the range of 5–30 min at 40°C, and was found to slightly affect the fluorescence (figure 3c). A heating duration of 5 min at 40°C was chosen as favourable heating conditions. The relationship between incubation time and GQDs fluorescence intensity was investigated, as shown in figure 3d. GQDs fluorescence intensity was quenched upon the addition of propofol, and the incubation time was studied within the range of 10–60 min. The fluorescence quenching produced upon the addition of GQDs became stable after 30 min of incubation time, and this slightly decreased thereafter. After the optimization of the relationship between incubation time and GQDs, further experiments were conducted using 30 min as the incubation duration.
3.4. Quantitative detection of propofol
Using the above-optimized conditions, the quenching effect of propofol on GQDs fluorescence intensity was further studied. As shown in figure 4, the fluorescence spectra of GQDs under different propofol concentrations were determined with the presence of 20 mmol l−1 of H2O2 and 2.5 mg ml−1 of HRP. It was observed that with the increase in propofol concentrations, the quenching amount also gradually increased. A good linear correlation was achieved within the range of 5.34–89.07 mg l−1, R2 = 0.9932 (figure 4). The linear regression equation was F/F0 = 0.9620−0.0013 C(propofol) (mg l−1). The limit of detection (LOD) was 0.5 mg l−1 and the limit of quantity (LOQ) was 5.34 mg l−1. The data show the average of three independent experiments (n = 3). In table 1, the detection limits and linear ranges of the experiments are consistent with previous reports. Results using the standard addition methods are shown in table 2. The average recoveries from 112.6% to 118.4% were observed in real samples, and the relative standard deviation (RSD) was less than 0.95%, indicating the potential of the GQDs and HRP system for detecting propofol in emulsion injection samples.
Figure 4.
The relationship between fluorescence quenching and the different concentration of propofol is shown (from top: 0, 5.34, 10.69, 21.38, 35.63, 53.44, 71.26 and 89.07 mg l−1).
Table 1.
Comparison of the present method with the reported methods for the determination of propofol.
Table 2.
Analysis of propofol in emulsion injection samples.
| Leweijing propofol injection emulsion (mg l−1) | propofol |
|||
|---|---|---|---|---|
| added | found | recovery (%) | RSD (n = 3, %) | |
| sample 1 | 21.38 | 24.04 ± 0.23 | 112.6 | 0.95 |
| sample 2 | 26.36 | 30.95 ± 0.13 | 117.4 | 0.41 |
| sample 3 | 31.35 | 37.14 ± 0.28 | 118.4 | 0.75 |
3.5. Sample determination
Three batches of Leweijing propofol injection emulsion were obtained. The samples were dissolved in 96% ethanol. The lipophilic analyte propofol in the emulsion was completely dissolved in 96% ethanol. The determination of samples from each batch was repeated three times. The average contents of the three batches of propofol emulsion were determined as 9.84, 9.78 and 9.82 mg ml−1, respectively (RSD < 5.0%). Recoveries of propofol within the range of 112.6–118.4% suggest that the method produced satisfactory results for practical applications, although the sensitivity of the method needs to be further improved. This method can be used for actual propofol determination in emulsions.
3.6. Interference study
Propofol injectable emulsion contains propofol in a 1% (w/v) oil-in-water sterilized emulsion, which also contains 100 mg ml−1 soybean oil, 22.5 mg ml−1 glycerol, 12 mg ml−1 lecithin and sodium hydroxide for pH adjustment. The pH of the emulsion was 7.0–8.5. The excipients in the injection emulsion may interfere with the determination of GQDs. The influence of some excipients, including soya bean oil, glycerol and lecithin, were investigated (figure 5). The highest concentration was considered as the tolerance of each coexistence substrate, with a relative error less than ±5%. The result indicated that the excipients did not interfere with the determination, which further signifies the high selectivity of the proposed method for determining propofol in emulsions.
Figure 5.
The FL response of the sensing system in the presence of soybean oil, glycerol, lecithin and propofol.
3.7. High-performance liquid chromatography method validation
The HPLC analysis was conducted using a Shimadzu chromatographic system, which consists of a LC-20AT pump with an automatic injector, and a SPD-M20A diode array detector. Separation was achieved with the Shim-pack VP-ODS C18 column (5 µm, 250 × 4.6 mm internal diameter; Shimadzu) maintained at 40°C. The chromatographic run was performed at 1 ml min−1 with a gradient elution of a mobile phase, which consisted of Solution A (0.02 mol l−1 of NaH2PO4 buffer, pH 3.0) and Solution B (Acetonitrile). The percentage of organic modifier (B) was as follows in a linear change: 0 min, 40%; 22 min, 40%; 38 min, 70%; 40 min, 70%; 41 min, 90%; 45 min, 90%; 46 min, 40%. The injection volume was 20 µl and total analysis run time was 46 min. The detection wavelength was 275 nm. The propofol injection emulsion was diluted with anhydrous ethanol as a test solution. The propofol standard solution was also diluted with anhydrous ethanol, and the concentration was maintained at 1.0 mg ml−1. This was used as an external standard for quantitative analysis.
A comparison of the propofol determination that resulted from samples using the GQDs method and HPLC method is presented in table 3. After conducting the Wilcoxon signed-rank test (inspection level: α = 0.05), the concentrations of propofol in the emulsion obtained by the two types of measurement methods revealed no significant differences (p > 0.05).
Table 3.
Concentrations of propofol in emulsion using the GQD and HPLC methods.
| Leweijing propofol injection emulsion | measured concentration (mg ml−1) |
|
|---|---|---|
| GQDs method | HPLC method | |
| sample 1 | 9.84 ± 0.15 | 9.57 ± 0.36 |
| sample 2 | 9.78 ± 0.28 | 10.16 ± 0.27 |
| sample 3 | 9.82 ± 0.32 | 10.00 ± 0.25 |
4. Conclusion
A novel propofol detection method based on GQDs was established. GQDs were obtained through CA pyrolysis and characterized by UV–Vis absorption spectrum, fluorescence emission spectrum, FTIR spectroscopy and TEM. Under conditions of H2O2 and HRP, propofol could be oxidized to a product that could effectively quench GQDs fluorescence. A fluorescence quenching quantitative relationship between propofol oxidation products and GQDs was established. The fluorescence spectrophotometric method for the detection of propofol in the emulsion was developed and validated with HPLC. The developed approach is simple, non-toxic, environment-friendly and easy to perform. The developed approach not only provides a novel method for the detection of propofol in emulsion but also gives the new potential application of GQDs in pharmaceutical analysis.
Acknowledgements
We thank Prof. Arkin Iburaim of the Central Laboratory of Xinjiang Medical University and Associate Prof. Cheng Ma of the Pharmaceutical Chemistry/Organic Chemistry Department, College of Pharmacy, Xinjiang Medical University for their support.
Data accessibility
This article does not contain any additional data.
Authors' contributions
J.D. carried out the fluorescence detection of graphene quantum dots and drafted the manuscript; T.W. synthesized graphene quantum dots, and studied the structural characterization of graphene quantum dots; L.L. carried out the design of the study, and collected and analysed the data. All the authors gave their final approval for publication.
Competing interests
The authors declare no competing interests.
Funding
This work was financially supported by the National Natural Science Foundation of China (grant no. 81760645). The project team members include L.L., J.D. and T.W.
References
- 1.Pan D, Zhang J, Li Z, Wu M. 2010. Hydrothermal route for cutting graphene sheets into blue-luminescent graphene quantum dots. Adv. Mater. 22, 734–738. ( 10.1002/adma.200902825) [DOI] [PubMed] [Google Scholar]
- 2.Gao T, Wang X, Yang L, He H, Ba XX, Zhao J, Jiang FL, Liu Y. 2017. Red, yellow, and blue luminescence by graphene quantum dots: syntheses, mechanism, and cellular imaging. ACS Appl. Mater. Interfaces 9, 24846 ( 10.1021/acsami.7b05569) [DOI] [PubMed] [Google Scholar]
- 3.Li C, Yue Y. 2014. Fluorescence spectroscopy of graphene quantum dots: temperature effect at different excitation wavelengths. Nanotechnology 25, 435703 ( 10.1088/0957-4484/25/43/435703) [DOI] [PubMed] [Google Scholar]
- 4.Štengl V, Bakardjieva S, Henych J, Lang K, Kormunda M. 2013. Blue and green luminescence of reduced graphene oxide quantum dots. Carbon 63, 537–546. ( 10.1016/j.carbon.2013.07.031) [DOI] [Google Scholar]
- 5.Li L, Wu G, Yang G, Peng J, Zhao J, Zhu JJ. 2013. Focusing on luminescent graphene quantum dots: current status and future perspectives. Nanoscale 5, 4015–4039. ( 10.1039/C3NR33849E) [DOI] [PubMed] [Google Scholar]
- 6.Sk MA, Ananthanarayanan A, Huang L, Lim KH, Chen P. 2014. Revealing the tunable photoluminescence properties of graphene quantum dots. J. Mater. Chem. C 2, 6954–6960. ( 10.1039/C4TC01191K) [DOI] [Google Scholar]
- 7.Dong Y, Shao J, Chen C, Li H, Wang R, Chi Y, Lin X, Chen G. 2012. Blue luminescent graphene quantum dots and graphene oxide prepared by tuning the carbonization degree of citric acid. Carbon 50, 4738–4743. ( 10.1016/j.carbon.2012.06.002) [DOI] [Google Scholar]
- 8.Wang Y, Zhang L, Liang RP, Bai JM, Qiu JD, Chem A. 2013. Using graphene quantum dots as photoluminescent probes for protein kinase sensing. Anal. Chem. 85, 9148–9155. ( 10.1021/ac401807b) [DOI] [PubMed] [Google Scholar]
- 9.Qian ZS, Shan XY, Chai LJ, Ma JJ, Chen JR, Feng H. 2014. DNA nanosensor based on biocompatible graphene quantum dots and carbon nanotubes. Biosens. Bioelectron. 60, 64 ( 10.1016/j.bios.2014.04.006) [DOI] [PubMed] [Google Scholar]
- 10.Wang GL, Fang X, Wu XM, Hu XL, Li ZJ. 2016. Label-free and ratiometric detection of nuclei acids based on graphene quantum dots utilizing cascade amplification by nicking endonuclease and catalytic G-quadruplex DNAzyme. Biosens. Bioelectron. 81, 214–220. ( 10.1016/j.bios.2016.02.038) [DOI] [PubMed] [Google Scholar]
- 11.Dong Y, Li G, Zhou N, Wang R, Chi Y, Chen G. 2012. Graphene quantum dot as a green and facile sensor for free chlorine in drinking water. Anal. Chem. 84, 8378–8382. ( 10.1021/ac301945z) [DOI] [PubMed] [Google Scholar]
- 12.Tam TV, Trung NB, Kim HR, Jin SC, Choi WM. 2014. One-pot synthesis of N-doped graphene quantum dots as a fluorescent sensing platform for Fe 3+ ions detection. Sensors Actuators B Chem. 202, 568–573. ( 10.1016/j.snb.2014.05.045) [DOI] [Google Scholar]
- 13.He Y, Sun J, Feng D, Chen H, Gao F, Wang L. 2015. Graphene quantum dots: highly active bifunctional nanoprobes for nonenzymatic photoluminescence detection of hydroquinone. Biosens. Bioelectron. 74, 418–422. ( 10.1016/j.bios.2015.07.006) [DOI] [PubMed] [Google Scholar]
- 14.Zhou X, Gao XX, Song FY, Wang CP, Chu FX, Wu SS. 2017. A sensing approach for dopamine determination by boronic acid-functionalized molecularly imprinted graphene quantum dots composite. Appl. Surf. Sci. 423, 810–816. ( 10.1016/j.apsusc.2017.06.199) [DOI] [Google Scholar]
- 15.Gokhale R, Singh P. 2014. Blue luminescent graphene quantum dots by photochemical stitching of small aromatic molecules: fluorescent nanoprobes in cellular imaging. Part. Part. Syst. Charact. 31, 433–438. ( 10.1002/ppsc.201300294) [DOI] [Google Scholar]
- 16.Chen J, Than A, Li N, Ananthanarayanan A, Zheng X, Xi F, Liu J, Tian J, Chen P. 2017. Sweet graphene quantum dots for imaging carbohydrate receptors in live cells. Flatchem 5, 25–32. ( 10.1016/j.flatc.2017.08.006) [DOI] [Google Scholar]
- 17.Benítez-Martínez S, Valcárcel M. 2015. Graphene quantum dots in analytical science. Trends Anal. Chem. 72, 93–113. [Google Scholar]
- 18.Shi B, Zhang L, Lan C, Zhao J, Su Y, Zhao S. 2015. One-pot green synthesis of oxygen-rich nitrogen-doped graphene quantum dots and their potential application in pH-sensitive photoluminescence and detection of mercury(II) ions. Talanta 142, 131–139. ( 10.1016/j.talanta.2015.04.059) [DOI] [PubMed] [Google Scholar]
- 19.He Y, Wang X, Sun J, Jiao S, Chen H, Gao F, Wang L. 2014. Fluorescent blood glucose monitor by hemin-functionalized graphene quantum dots based sensing system. Anal. Chim. Acta 810, 71–78. ( 10.1016/j.aca.2013.11.059) [DOI] [PubMed] [Google Scholar]
- 20.Li Y, Huang H, Ma Y, Tong J. 2014. Highly sensitive fluorescent detection of dihydroxybenzene based on graphene quantum dots. Sensors Actuators B Chem. 205, 227–233. ( 10.1016/j.bios.2014.12.057) [DOI] [Google Scholar]
- 21.Sun R, Wang Y, Ni Y, Kokot S. 2014. Graphene quantum dots and the resonance light scattering technique for trace analysis of phenol in different water samples. Talanta 125, 341–346. ( 10.1016/j.talanta.2014.03.007) [DOI] [PubMed] [Google Scholar]
- 22.Huang H, Feng Z, Li Y, Liu Z, Zhang L, Ma Y, Tong J. 2015. Highly sensitive detection of bisphenol A in food packaging based on graphene quantum dots and peroxidase. Anal. Methods 7, 2928–2935. ( 10.1039/c4ay03080j) [DOI] [Google Scholar]
- 23.Zhou Y, Qu ZB, Zeng Y, Zhou T, Shi G. 2014. A novel composite of graphene quantum dots and molecularly imprinted polymer for fluorescent detection of paranitrophenol. Biosens. Bioelectron. 52, 317 ( 10.1016/j.bios.2013.09.022) [DOI] [PubMed] [Google Scholar]
- 24.Benítez-Martínez S, Valcárcel M. 2014. Graphene quantum dots as sensor for phenols in olive oil. Sensors Actuators B Chem. 197, 350–357. ( 10.1016/j.snb.2014.03.008) [DOI] [Google Scholar]
- 25.Kivlehan F, Chaum E, Lindner E. 2015. Propofol detection and quantification in human blood: the promise of feedback controlled, closed-loop anesthesia. Analyst 140, 98–106. ( 10.1039/c4an01483a) [DOI] [PubMed] [Google Scholar]
- 26.Hong C, Chang P, Lin C, Hong C. 2010. A disposable microfluidic biochip with on-chip molecularly imprinted biosensors for optical detection of anesthetic propofol. Biosens. Bioelectron. 25, 2058–2064. ( 10.1016/j.bios.2010.01.037) [DOI] [PubMed] [Google Scholar]
- 27.Hornuss C, Dolch ME, Janitza S, Souza K, Praun S, Apfel CC, Schelling G. 2013. Determination of breath isoprene allows the identification of the expiratory fraction of the propofol breath signal during real-time propofol breath monitoring. J. Clin. Monit. Comput. 27, 509–516. ( 10.1007/s10877-013-9452-7) [DOI] [PubMed] [Google Scholar]
- 28.Kamysek S, Fuchs P, Schwoebel H, Roesner JP, Kischkel S, Wolter K, Loeseken C, Schubert JK, Miekisch W. 2011. Drug detection in breath: effects of pulmonary blood flow and cardiac output on propofol exhalation. Anal. Bioanal. Chem. 401, 2093 ( 10.1007/s00216-011-5099-8) [DOI] [PubMed] [Google Scholar]
- 29.Sung PJ. 2016. Selective and accurate determination method of propofol in human plasma by mixed-mode cation exchange cartridge and GC-MS. J.Anal. Methods Chem. 2016, 1–5. ( 10.1155/2016/9531769) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.El Hamd MA, Wada M, Ikeda R, Kawakami S, Nakashima K. 2015. Validation of an LC-MS/MS method for the determination of propofol, midazolam, and carbamazepine in rat plasma: application to monitor their concentrations following co-administration. Biol. Pharm. Bull. 38, 1250–1253. ( 10.1248/bpb.b15-00191) [DOI] [PubMed] [Google Scholar]
- 31.Cussonneau X, Smet ED, Lantsoght K, Salvi JP, Bolon-Larger M, Boulieu R. 2007. A rapid and simple HPLC method for the analysis of propofol in biological fluids. J. Pharm. Biomed. Anal. 44, 680–682. ( 10.1016/j.jpba.2006.10.020) [DOI] [PubMed] [Google Scholar]
- 32.Hui Y, Raedschelders K, Zhang H, Ansley DM, Chen DD. 2009. Quantitative analysis of propofol in whole blood using capillary electrophoresis. J. Chromatogr. B 877, 703–709. ( 10.1016/j.jchromb.2009.01.030) [DOI] [PubMed] [Google Scholar]
- 33.Šrámková I, Amorim CG, Sklenářová H, Montenegro MC, Horstkotte B, Araújo AN, Solich P. 2014. Fully automated analytical procedure for propofol determination by sequential injection technique with spectrophotometric and fluorimetric detections. Talanta 118, 104 ( 10.1016/j.talanta.2013.09.059) [DOI] [PubMed] [Google Scholar]
- 34.Li L, Li Y. 2016. Study of azo-coupling derivatization by sequential injection coupled with spectrophotometric optical fibre detection for propofol analysis. Anal. Methods. 8, 6176–6184. ( 10.1039/C6AY01047D) [DOI] [Google Scholar]
- 35.Cowley NJ, Laitenberger P, Liu B, Jarvis J, Clutton-Brock TH. 2012. Evaluation of a new analyser for rapid measurement of blood propofol concentration during cardiac surgery. Anaesthesia 67, 870 ( 10.1111/j.1365-2044.2012.07151.x) [DOI] [PubMed] [Google Scholar]
- 36.Vries AD, Taylor PM, Troughton G, Liu B, Fowden AL, Sear JW. 2013. Real time monitoring of propofol blood concentration in ponies anaesthetized with propofol and ketamine. J. Vet. Pharmacol. Ther. 36, 258–266. ( 10.1111/j.1365-2885.2012.01422.x) [DOI] [PubMed] [Google Scholar]
- 37.Li L, Ding H, Di B, Li W, Chen J. 2012. Rapid detection of propofol in whole blood using an automated on-line molecularly imprinted pretreatment coupled with optical fibre detection. Analyst. 137, 5632–5638. ( 10.1039/c2an35523j) [DOI] [PubMed] [Google Scholar]
- 38.Wang S, Chen ZG, Cole I, Li Q. 2015. Structural evolution of graphene quantum dots during thermal decomposition of citric acid and the corresponding photoluminescence. Carbon 82, 304–313. ( 10.1016/j.carbon.2014.10.075) [DOI] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
This article does not contain any additional data.





